MSDS 0993 Ultra Perfex 2
MSDS 0993 Ultra Perfex 2
MSDS 0993 Ultra Perfex 2
1.2 Relevant identified uses of the substance or mixture and uses advised against
Product use : Consumer applications, Professional applications.
Use of the substance/ : Coating.
mixture
The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended.
Classification according to Directive 1999/45/EC [DPD]
The product is not classified as dangerous according to Directive 1999/45/EC and its amendments.
Classification : Not classified.
See Section 16 for the full text of the R phrases or H statements declared above.
See Section 11 for more detailed information on health effects and symptoms.
Classification
Product/ingredient Identifiers % by 67/548/EEC Regulation (EC) No. Type
name
weight 1272/2008 [CLP]
Talc (Mg3H2(SiO3)4) EC: 238-877-9 ≥10 - Not classified. Not classified. [2]
<25
CAS: 14807-96-6
calcium carbonate REACH #: ≥5 - Not classified. Not classified. [2]
01-2119486795-18 <10
EC: 207-439-9
CAS: 471-34-1
Silicic acid, aluminum REACH #: ≥3 - <5 Not classified. Not classified. [2]
magnesium sodium salt 01-2119403714-47
EC: 234-919-5
CAS: 12040-43-6
titanium dioxide REACH #: ≥1 - <3 Not classified. Not classified. [2]
01-2119489379-17
EC: 236-675-5
CAS: 13463-67-7
There are no additional ingredients present which, within the current knowledge of the supplier and in the concentrations
applicable, are classified as hazardous to health or the environment and hence require reporting in this section.
Type
[1] Substance classified with a health or environmental hazard
[2] Substance with a workplace exposure limit
[3] Substance meets the criteria for PBT according to Regulation (EC) No. 1907/2006, Annex XIII
[4] Substance meets the criteria for vPvB according to Regulation (EC) No. 1907/2006, Annex XIII
[5] Substance of equivalent concern
SUB codes represent substances without registered CAS Numbers.
4.2 Most important symptoms and effects, both acute and delayed
Potential acute health effects
Eye contact : No known significant effects or critical hazards.
Inhalation : No known significant effects or critical hazards.
Skin contact : No known significant effects or critical hazards.
Ingestion : No known significant effects or critical hazards.
Over-exposure signs/symptoms
Eye contact : No specific data.
Inhalation : No specific data.
Skin contact : No specific data.
Ingestion : No specific data.
4.3 Indication of any immediate medical attention and special treatment needed
Notes to physician : Treat symptomatically. Contact poison treatment specialist immediately if large
quantities have been ingested or inhaled.
Specific treatments : No specific treatment.
6.2 Environmental : Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains
precautions and sewers. Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air).
PNECs
PNECs - Not available.
10.3 Possibility of : Under normal conditions of storage and use, hazardous reactions will not occur.
hazardous reactions
10.4 Conditions to avoid : When exposed to high temperatures may produce hazardous decomposition
products.
Refer to protective measures listed in sections 7 and 8.
10.5 Incompatible materials : Keep away from the following materials to prevent strong exothermic reactions:
oxidising agents, strong alkalis, strong acids.
10.6 Hazardous : Decomposition products may include the following materials: carbon monoxide,
decomposition products carbon dioxide, smoke, oxides of nitrogen.
Irritation/Corrosion
Conclusion/Summary : Not available.
Sensitisation
Conclusion/Summary : Not available.
Mutagenicity
Conclusion/Summary : Not available.
Carcinogenicity
Conclusion/Summary : Not available.
Reproductive toxicity
Conclusion/Summary : Not available.
Teratogenicity
Conclusion/Summary : Not available.
Specific target organ toxicity (single exposure)
Not available.
Aspiration hazard
Not available.
Repeated or prolonged contact with the mixture may cause removal of natural fat from the skin, resulting in non-
allergic contact dermatitis and absorption through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Packaging
Methods of disposal : The generation of waste should be avoided or minimised wherever possible. Waste
packaging should be recycled. Incineration or landfill should only be considered
when recycling is not feasible.
Type of packaging European waste catalogue (EWC)
Container 15 01 06 mixed packaging
Additional information
ADR/RID : None identified.
IMDG : None identified.
IATA : None identified.
Special precautions for user : Transport within user’s premises: always transport in closed containers that are
upright and secure. Ensure that persons transporting the product know what to do in
the event of an accident or spillage.